Neurodegeneration, an continuous decline in the health of neurons, presents a significant challenge to modern medicine. While there is currently no cure for neurodegenerative disorders, researchers are constantly exploring innovative therapeutic approaches. One such direction of research involves deschloroketamine, a analog of the anesthetic ketami